Patients most likely to benefit from PANXEON screening include individuals with inherited genetic risk, a family history of pancreatic cancer, pancreatic cysts, or chronic pancreatitis.

From the articleNovel blood test could detect pancreatic cancer at its earliest stagesAlso in Blood test shows promise for detecting pancreatic cancer at its earliest stages